Support

Risdiplam studies

Example dataset · Rare disease · From CTIS, ClinicalTrials.gov and the EU Clinical Trials Register · Data as of 9 Oct 2026

Which registered studies name risdiplam as an intervention?

Ask your AI

Give this dataset to your own AI assistant to check. It reads a plain-text copy of every study, with each registry's values and record links. Atlas does not summarise it.

Open in ChatGPTOpen in Claude

Anyone with this dataset's link can read the text copy too: open it.

Export

Every study in this dataset, with its columns. A Sources table cites every value: the registry, record, field, link and date.

Ask your own AI assistant about it. The file explains its columns, and every value names the registry record it came from, so you can check what the assistant tells you.

Needs a free Atlas account. Sign up or sign in, and you come back here to download it.

In 7 of 21 studies, registry records state different values for at least one field. Show these studiesOne row per study · registries kept separate
StudySponsorConditionsPhase and statusEnrolmentPrimary completion
Registry records state different values for start date.
Registry records state different values for start date.
Registry records state different values for recruitment status, start date.
Registry records state different values for recruitment status.
Loading more studies…

Ask Atlas your own question

Describe the studies you want in your own words. Atlas proposes a dataset from the registry records it holds, with every value cited to its record.

Ask your own question
Other examplesDatopotamab deruxtecan studiesAnti-TL1A antibody studies

Sources

Data from the EU Clinical Trials Information System (CTIS), via the European Medicines Agency's public portal. Source: European Medicines Agency. The European Medicines Agency does not endorse this page. Each record links to CTIS, with the date Atlas accessed it where this data holds it.

Data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine, National Institutes of Health. ClinicalTrials.gov is a U.S. Government database, and PhaseFolio claims no proprietary right in its data. Each record links to ClinicalTrials.gov; the date ClinicalTrials.gov last processed it (Last update posted) is in the study's record where this data holds it.

Data from the EU Clinical Trials Register (EudraCT), European Medicines Agency. Each record links to the register, with the date Atlas accessed it where this data holds it. Values stay at the register's grain: one record per member state.

PhaseFolio keeps every registry's own value. Values that differ between records are shown side by side, never merged, ranked or resolved. Phase and recruitment status read with PhaseFolio's labels for each registry's codes; a value outside those labels reads as Not mapped, with its reason. A value a registry does not give reads as a labelled state, such as Not reported, never as a blank or a guess.

Atlas shows what registry records state. It does not rank studies, interpret results or give clinical advice. Data as of 9 Oct 2026.